Zinc in human malignancies.
Serum zinc level (SZL) was determined in normal patients and in patients with primary tumors of different sites, with measurements made before and after therapy. Serum zinc concentration was depressed in some of the tumor types examined. In some cases serum zinc concentration increased again after successful treatment. Diagnostic and prognostic value of the serum zinc concentration in malignancy is discussed.
D001943:Breast Neoplasms / Q000097:blood; D003300:Copper / Q000097:blood; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000097:blood; D006258:Head and Neck Neoplasms / Q000097:blood; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009369:Neoplasms / Q000097:blood* / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D013054:Spectrophotometry, Atomic; D014565:Urogenital Neoplasms / Q000097:blood; D002583:Uterine Cervical Neoplasms / Q000097:blood; D015032:Zinc / Q000097:blood*
D003300:Copper; D015032:Zinc